ZVRA Earnings Zevra Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.60 | 2026-05-06 | 10-Q |
| FY 2025 | 2025-12-31 | 1.35 | 2026-03-09 | 10-K |
| Q3 2025 | 2025-09-30 | 1.16 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | 1.16 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.06 | 2026-05-06 | 10-Q |
| FY 2025 | 2024-12-31 | -2.28 | 2026-03-09 | 10-K |
| Q3 2025 | 2024-09-30 | -1.59 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.87 | 2025-08-12 | 10-Q |
| FY 2021 | 2021-12-31 | -2.11 | 2022-03-31 | 10-K |
| Q3 2021 | 2021-09-30 | -2.16 | 2021-11-10 | 10-Q |
| Q2 2021 | 2021-06-30 | -2.42 | 2021-08-13 | 10-Q |
| Q1 2021 | 2021-03-31 | -2.49 | 2021-05-14 | 10-Q |
| FY 2021 | 2020-12-31 | -3.21 | 2022-03-31 | 10-K |
| Q3 2021 | 2020-09-30 | -2.08 | 2021-11-10 | 10-Q |
| Q2 2021 | 2020-06-30 | -1.43 | 2021-08-13 | 10-Q |
| Q1 2021 | 2020-03-31 | -1.92 | 2021-05-14 | 10-Q |
| Q3 2020 | 2019-09-30 | -0.65 | 2020-10-30 | 10-Q |
| Q2 2020 | 2019-06-30 | -0.78 | 2020-08-12 | 10-Q |
| Q3 2019 | 2018-09-30 | -3.33 | 2019-11-14 | 10-Q |
| Q2 2019 | 2018-06-30 | -2.41 | 2019-08-13 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.